Observational Study for Chronic Kidney Disease
This is an observational study looking at chronic kidney disease (CKD) and glomerulopathy. Researchers want to understand more about CKD, which affects many Americans and can lead to serious health problems. They are studying people of all ages who have CKD, which means they have abnormally high protein in their urine or reduced kidney function. A small number of people without CKD can also join. You cannot participate if you are on dialysis, have had a kidney transplant, or are unable to provide consent. The study aims to enroll 1800 participants. The current recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will collect information without giving any specific treatments. It plans to include 1800 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center
At a glance
A primary outcome measure isn't published for this study.
Conditions
Where it's being run
5 sites across 3 statesStudy leadership
- Subramanium Pennathur, MBBS · PRINCIPAL_INVESTIGATOR · University of Michigan
- Crystal A Gadegbeku, MD · STUDY_DIRECTOR · The Cleveland Clinic
- Matthias Kretzler, MD · STUDY_DIRECTOR · University of Michigan
- Markus Bitzer, MD · STUDY_DIRECTOR · University of Michigan
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.